Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
NEEDHAM INVESTMENT MANAGEMENT LLC RSSS Research Solutions, Inc. 13G 5.21% 2y
BioNTech SE AUTL Autolus Therapeutics plc 13D 12.5% 2y
Starboard Value LP ALIT Alight, Inc. / Delaware 13D 7.8% 2y
Orin Hirschman BWAY Brainsway Ltd. 13G/A 4.1% 2y
WOLVERINE ASSET MANAGEMENT LLC KRNL Kernel Group Holdings, Inc. Class A Ordinary Shares 13G/A 0.3% 2y
Group of Trophy, LLC GIPR Generation Income Properties, Inc. 13G 6.8% 2y
Darin Feinstein CORZ Core Scientific, Inc. 13D/A 9.4% 2y
WOLVERINE ASSET MANAGEMENT LLC TCOA Zalatoris Acquisition Corp. 13G/A 2.75% 2y
Fahar Merchant MDNAF Medicenna Therapeutics Corp. 13G/A 29.1% 2y
Zalupski Patrick O. DFH Dream Finders Homes, Inc. 13G 65.6% 2y
Lovett William Radford II DFH Dream Finders Homes, Inc. 13G 15.4% 2y
ATLANTIC FAMILY WEALTH, LLC ABI Victory Portfolios II 13G 5.7% 2y
Raymond T. Hyer HRTG Heritage Insurance Holdings, Inc. 13G/A 13.75% 2y
Reagan Lovig AVNI Arvana Inc 13G 5.56% 2y
Fredric N. Eshelman GTHX G1 Therapeutics, Inc. Common Stock 13D/A 9.26% 2y
Lynne E. Peterson ELSE Electro Sensors Inc 13D/A 10.2% 2y
BT Parent GP, LLC RPAY Repay Holdings Corp 13D 9.41% 2y
Oasis Management Co Ltd. STRS Stratus Properties Inc 13D/A 14.5% 2y
Runa Capital Opportunity I (GP) MRDB MariaDB plc 13D/A 4% 2y
Saba Capital Management, L.P. MPA Blackrock Muniyield Pennsylvania Quality Fund 13D/A 15.5% 2y
Saba Capital Management, L.P. BMEZ BlackRock Health Sciences Term Trust 13D/A 17.94% 2y
Saba Capital Management, L.P. ECAT BlackRock ESG Capital Allocation Term Trust 13D/A 25.89% 2y
Socrates Trust APO Apollo Global Management, Inc. 13D/A 5.8% 2y
L. W. Van Loan Trust dated September 8, 2006 AP Ampco Pittsburgh Corp 13D/A 4.9% 2y
Saba Capital Management, L.P. MYN Blackrock Muniyield New York Quality Fund, Inc. 13D/A 5.4% 2y
BLACK, LEON D APO Apollo Global Management, Inc. 13D/A 7.9% 2y
Saba Capital Management, L.P. BCAT BlackRock Capital Allocation Term Trust 13D/A 13.56% 2y
Chad Richison PAYC Paycom Software, Inc. 13D/A 11.8% 2y
FAIRFAX FINANCIAL HOLDINGS LTD/ CAN BB BLACKBERRY Ltd 13D/A 8.1% 2y
Saba Capital Management, L.P. BTX BlackRock Technology & Private Equity Term Trust 13D/A 21.66% 2y
Elliott Investment Management L.P. BTU Peabody Energy Corp 13D/A 7.3% 2y
Sessa Capital (Master), L.P. GTX Garrett Motion Inc. 13G/A 10.6% 2y
CYRUS CAPITAL PARTNERS, L.P. ICMB Investcorp Credit Management BDC, Inc. 13D/A 6.3% 2y
Saba Capital Management, L.P. BSTZ BlackRock Science & Technology Term Trust 13D/A 6.28% 2y
Camac Partners, LLC ABCP AmBase Corp 13D/A 10.4% 2y
PAVmed Inc. LUCD Lucid Diagnostics Inc. 13D/A 65.2% 2y
Phoenix Financial Ltd. SMWB Similarweb Ltd. 13G/A 4.88% 2y
Jurgen van de Vyver CERO Cero Therapeutics Holdings, Inc. 13D/A 6.8% 2y
RS Fund LP NURO NeuroMetrix, Inc. Common Stock 13G 14.4% 2y
Max Gottschalk PMNT Perfect Moment Ltd. 13D 23% 2y
Harraden Circle Investments, LLC CPTKW Crown PropTech Acquisitions 13G 9.99% 2y
GILEAD SCIENCES, INC. KYTX Kyverna Therapeutics, Inc. 13G 9.6% 2y
David B. Blundin EVER EverQuote, Inc. 13D/A 28.3% 2y
Trung T. Doan LEDS SemiLEDs Corp 13D/A 17.89% 2y
Luxor Capital Group, LP FIP FTAI Infrastructure Inc. 13G 5% 2y
Mike Edward McAleer SYRA Syra Health Corp 13G 0% 2y
Quint Digital Ltd LEE LEE ENTERPRISES, Inc 13G 8.4% 2y
S.H.N. Financial Investments Ltd. TENX Tenax Therapeutics, Inc. 13G 5.6% 2y
MMCAP International Inc. SPC ASTL Algoma Steel Group Inc. 13G 6.5% 2y
TCG Crossover GP I, LLC KALV KalVista Pharmaceuticals, Inc. 13D/A 6.52% 2y